Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.

Type 2 diabetes mellitus (T2DM) is managed with combined lifestyle modifications and antidiabetic drugs, but people on treatment often fail to reach glycaemic control. Adherence is important for achieving optimal glycaemic control, and management of diabetes with drugs is a lifelong process, so unde...

Full description

Saved in:
Bibliographic Details
Main Authors: Tsaone Tamuhla, Peter Raubenheimer, Joel A Dave, Nicki Tiffin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0002730
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846129354229153792
author Tsaone Tamuhla
Peter Raubenheimer
Joel A Dave
Nicki Tiffin
author_facet Tsaone Tamuhla
Peter Raubenheimer
Joel A Dave
Nicki Tiffin
author_sort Tsaone Tamuhla
collection DOAJ
description Type 2 diabetes mellitus (T2DM) is managed with combined lifestyle modifications and antidiabetic drugs, but people on treatment often fail to reach glycaemic control. Adherence is important for achieving optimal glycaemic control, and management of diabetes with drugs is a lifelong process, so understanding adherence through analysis of longitudinal medications data is important. Using retrospective routine health data and metformin dispensing records as a proxy for medication use, we describe longitudinal persistence and adherence to oral diabetes medication in a virtual cohort of 10541 people with diabetes (PLWD) in Khayelitsha subdistrict, Cape Town. Adherence was measured in 120-day sliding windows over two years and used to estimate metformin adherence trajectories. Multinomial logistic regression identified factors influencing these trajectories. Analysis of pharmacy dispensing records showed varying medication refill patterns: while some PLWD refilled prescriptions consistently, others had treatment gaps with periods of non-persistence and multiple treatment episodes-from one to five per individual across two years. There was a general trend of decreasing adherence over time across all sliding windows in the two-year period, with only 25% of the study population achieved medication adherence (> = 80% adherence) after two years. Four adherence trajectories; 'low adherence gradual decline (A), 'high adherence rapid decline' (B), 'low adherence gradual increase (C) and 'adherent' (D) were identified. Only trajectory D represented participants who were adherent at treatment start and remained adherent after two years. Taking HIV antiretroviral treatment before or concurrently with diabetes treatment and taking metformin in combination with sulphonylurea and/or insulin were associated with the long-term adherence (trajectory D). Routine data shows real life medication implementation patterns which might not be seen under controlled study conditions. This study illustrates the utility of these data in describing longitudinal adherence patterns at both an individual and population level.
format Article
id doaj-art-de467245158a4fdba81a11dfe661c223
institution Kabale University
issn 2767-3375
language English
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj-art-de467245158a4fdba81a11dfe661c2232024-12-10T05:53:03ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752023-01-01312e000273010.1371/journal.pgph.0002730Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.Tsaone TamuhlaPeter RaubenheimerJoel A DaveNicki TiffinType 2 diabetes mellitus (T2DM) is managed with combined lifestyle modifications and antidiabetic drugs, but people on treatment often fail to reach glycaemic control. Adherence is important for achieving optimal glycaemic control, and management of diabetes with drugs is a lifelong process, so understanding adherence through analysis of longitudinal medications data is important. Using retrospective routine health data and metformin dispensing records as a proxy for medication use, we describe longitudinal persistence and adherence to oral diabetes medication in a virtual cohort of 10541 people with diabetes (PLWD) in Khayelitsha subdistrict, Cape Town. Adherence was measured in 120-day sliding windows over two years and used to estimate metformin adherence trajectories. Multinomial logistic regression identified factors influencing these trajectories. Analysis of pharmacy dispensing records showed varying medication refill patterns: while some PLWD refilled prescriptions consistently, others had treatment gaps with periods of non-persistence and multiple treatment episodes-from one to five per individual across two years. There was a general trend of decreasing adherence over time across all sliding windows in the two-year period, with only 25% of the study population achieved medication adherence (> = 80% adherence) after two years. Four adherence trajectories; 'low adherence gradual decline (A), 'high adherence rapid decline' (B), 'low adherence gradual increase (C) and 'adherent' (D) were identified. Only trajectory D represented participants who were adherent at treatment start and remained adherent after two years. Taking HIV antiretroviral treatment before or concurrently with diabetes treatment and taking metformin in combination with sulphonylurea and/or insulin were associated with the long-term adherence (trajectory D). Routine data shows real life medication implementation patterns which might not be seen under controlled study conditions. This study illustrates the utility of these data in describing longitudinal adherence patterns at both an individual and population level.https://doi.org/10.1371/journal.pgph.0002730
spellingShingle Tsaone Tamuhla
Peter Raubenheimer
Joel A Dave
Nicki Tiffin
Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
PLOS Global Public Health
title Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
title_full Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
title_fullStr Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
title_full_unstemmed Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
title_short Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
title_sort routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the khayelitsha sub district of cape town south africa
url https://doi.org/10.1371/journal.pgph.0002730
work_keys_str_mv AT tsaonetamuhla routinehealthdatadescribeadherenceandpersistencepatternsfororaldiabetesmedicationforavirtualcohortinthekhayelitshasubdistrictofcapetownsouthafrica
AT peterraubenheimer routinehealthdatadescribeadherenceandpersistencepatternsfororaldiabetesmedicationforavirtualcohortinthekhayelitshasubdistrictofcapetownsouthafrica
AT joeladave routinehealthdatadescribeadherenceandpersistencepatternsfororaldiabetesmedicationforavirtualcohortinthekhayelitshasubdistrictofcapetownsouthafrica
AT nickitiffin routinehealthdatadescribeadherenceandpersistencepatternsfororaldiabetesmedicationforavirtualcohortinthekhayelitshasubdistrictofcapetownsouthafrica